Clinical Trials of Interest
Renal & Urology News has prepared this newsletter to help you keep current on the latest clinical trials in nephrology and urology.
The listings below, which are grouped by disease or condition, are based on information from the Clinical Trials website maintained by the National Institute of Health. Our listing is regularly updated. Only active trials are included.
To view more info about these go to
http://www.renalandurologynews.com/ongoing-clinical-trials/section/50/ Acute Kidney Injury
Effect of Red Wine, White Wine and Beer on Contrast-Medium Induced Acute Kidney Injury (RenPro-II-WINE)
Standard Versus Accelerated Initiation of Dialysis in Acute Kidney Injury (STARRT-AKI)
Evaluating Novel Biomarkers in Acute Kidney Injury
............................................
Diabetes Mellitus
Stress Management Among Latinos With Type 2 Diabetes (CALMS-D)
E-health Care Process Support for Diabetes Type II Patients (EHDI)
Mobile Diabetes Education Teams in Primary Care
............................................
Hyperphosphatemia
An Efficacy and Safety Study of Sevelamer Carbonate in Hyperphosphatemic Pediatric Patients With Chronic Kidney Disease
An Efficacy and Safety Study of Sevelamer Carbonate in Hyperphosphatemic Pediatric Patients With Chronic Kidney Disease
A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on Dialysis
............................................
Lupus Nephritis
Comparison Between Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) for Induction of Remission in Lupus Nephritis
Phase 2 Study of Human Umbilical Cord Derived Mesenchymal Stem Cell for the Treatment of Lupus Nephritis (hUC-MSC-SLE)
Safety Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Lupus Nephritis
............................................
Overactive Bladder
Painless Laser Therapy for Overactive Bladder (PLTOAB)
A Study to Investigate How Effective and Safe Solifenacin Liquid Suspension is in Treating Children/Adolescents Aged 5 to Less Than 18 Years With Symptoms of Overactive Bladder (OAB) Compared to a Non-active Drug (LION)
Study of Overactive Bladder in Women With Prolapse (SOAP)
............................................
Prostate Cancer
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Helping African American Prostate Cancer Survivors and Their Partners Cope With Challenges After Surgery for Prostate Cancer
Degarelix Prior to Prostatectomy for Patients With Intermediate and High Risk Prostate Cancer
............................................
Renal Obstruction
Renal Artery Contrast-Free Trial (REACT)
Medical and Endovascular Treatment of Atherosclerotic Renal Artery Stenosis (METRAS Study)
Stenting of Renal Artery Stenosis in Coronary Artery Disease Study (RASCAD)
............................................
Voiding Dysfunction
Treatment of Neurogenic Incontinence by Surgery to Cut the Filum Terminale (NICNOC)
Efficacy of Clean Intermittent Catheterization in MS Patients With Bladder Dysfunction
Efficacy and Safety of Silodosin on Voiding Dysfunction Associated With Neurogenic Bladder
............................................
Bladder Cancer
PlasmaKinetic (PK) Button Vaporization Electrode for Treatment of Bladder Tumors
Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer
Quality of Life in Patients With Bladder Cancer
............................................
Hemodialysis
Use of a Lifeline Graft in the A-V Shunt Model
Protein Intake, Nutrition and Cardiovascular Diseases in Stage V CKD
Outcome Study of Lanthanum Carbonate Compared With Calcium Carbonate in Hemodialysis Patients : Landmark Study (LANDMARK)
............................................
Kidney/Ureteral Stones
Differential Effect of Silodosin Versus Tamsulosin on Stone Clearance After Extra-corporeal Shock Wave Lithotripsy
Evaluating Ureteral Length Using Computed Tomography (CT) (URO-Y-2)
The Role Of FGF23, Klotho, And Sclerostin In Kidney Stone Formers
............................................
Nephrogenic Systemic Fibrosis
Adverse Reactions to MR and CT-examinations (Enhanced and Unenhanced)
Safety of Gadovist in Renally Impaired Patients (GRIP)
Nephrogenic Systemic Fibrosis (NSF): Analysis of Tissue Gadolinium Levels
............................................
Pelvic Prolapse
Physical Therapy on Quality of Life and Function Following Vaginal Surgery Reconstructive Surgery (PT and QOL)
Validation of a French Version of the PISQ-R
Systemic Markers of Collagen Metabolism and Vitamin C in Smokers and Non-Smokers With Pelvic Organ Prolapse
............................................
Renal Cell Carcinoma
Neoadjuvant Axitinib in Locally Advanced Renal Cell Carcinoma (RCC)
Genome-wide Association Study to Predict Treatment Response for Molecular Targeted Therapy in Hepatocellular Carcinoma and Renal Cell Carcinoma
Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC) (ADAPT)
............................................
Renal Transplant
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Everolimus Rescue Immunosuppression in the Treatment of Chronic Allograft Dysfunction in Renal Transplant Recipients
Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Crossmatch Deceased Donor Kidney Transplant
............................................
I Hate Dialysis Message Board
Author
